Constellation Brands (STZ) Gets a Buy from RBC Capital
In a report released today, Nik Modi from RBC Capital maintained a Buy rating on Constellation Brands, with a price target of $185.00.
4th of July Sale - 70% Off
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Modi covers the Consumer Defensive sector, focusing on stocks such as Church & Dwight, Constellation Brands, and Procter & Gamble. According to TipRanks, Modi has an average return of -1.4% and a 48.20% success rate on recommended stocks.
In addition to RBC Capital, Constellation Brands also received a Buy from Bernstein’s Nadine Sarwat in a report issued today. However, on the same day, Barclays reiterated a Hold rating on Constellation Brands (NYSE: STZ).
Based on Constellation Brands’ latest earnings release for the quarter ending May 31, the company reported a quarterly revenue of $2.43 billion and a net profit of $653.8 million. In comparison, last year the company earned a revenue of $2.51 billion and had a net profit of $516.1 million
Based on the recent corporate insider activity of 24 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of STZ in relation to earlier this year. Most recently, in May 2026, James O. Bourdeau, the EVP and Senior Advisor of STZ sold 4,407.00 shares for a total of $631,258.68.
Read More on STZ:
Disclaimer & DisclosureReport an Issue
- Constellation Brands: Buy Rating Reaffirmed as Fundamentals Improve and $197 Price Target Remains Unchanged
- Constellation Brands: Buy Rating Reaffirmed on Underappreciated Beer Growth and Earnings Power, Price Target Unchanged at $190
- Constellation Brands price target lowered to $145 from $152 at BofA
- Constellation Brands price target lowered to $158 from $183 at Morgan Stanley
- Constellation Brands price target lowered to $139 from $170 at Barclays
